J. S. Yadav et al. / Tetrahedron Letters 49 (2008) 4742–4745
4745
3
4
.
.
Krow, G. R. Tetrahedron 1981, 37, 1283–1307.
(a) McEwen, W. E.; Conrad, W. E.; Vanderwerf, C. A. J. Am. Chem. Soc. 1952, 74,
purified by column chromatography on silica gel (Merck, 100–200 mesh) using
ethyl acetate/hexane (4:6) as eluent to afford the pure derivative. Replacing
1
168–1171; (b) Smith, P. A. S.; Horwitz, J. P. J. Am. Chem. Soc. 1950, 72, 3718–
3 3
TMSN with NaN , the same procedure afforded the same products in relatively
3
722.
longer reaction times (Table 1).
5
6
.
.
For reviews, see: (a) Bräse, S.; Gil, C.; Knepper, K.; Zimmermann, V. Angew.
Chem., Int. Ed. 2005, 44, 5188–5240; (b) Lang, S.; Murphy, J. A. Chem. Soc. Rev.
Compound 3d: 1-azacyclotridecan-2-one
(Table 1, entry d): White solid,
mp = 143–145 °C. IR (KBr)
mmax: 3307, 3082, 2931, 2856, 1639, 1550, 1448,
1283, 1185, 739, 691 cm . 1H NMR (CDCl
1H), 3.21–3.12 (m, 2H), 2.14–2.09 (m, 2H), 1.64–1.19 (m, 18H); C NMR
(CDCl , 75 MHz): d 173.5, 38.9, 36.7, 28.1, 26.6, 26.2, 26.1, 25.6, 25.1, 24.8, 24.5,
À1
2
006, 35, 146–156; (c) Nyfeler, E.; Renaud, P. Chimia 2006, 60, 276–284.
3
+ DMSO, 200 MHz): d 7.23 (br s,
13
(a) Briggs, L. H.; De Ath, G. C.; Ellis, S. R. J. Chem. Soc. 1942, 61–63; (b) Smith, P.
A. S. J. Am. Chem. Soc. 1948, 70, 320–323; (c) Pearson, W. H.; Schkeryantz, J. M.
Tetrahedron Lett. 1992, 33, 5291–5294; (d) Pearson, W. H.; Walavalkar, R.;
Schkeryantz, J. M.; Fang, W.-k.; Blickensdorf, J. D. J. Am. Chem. Soc. 1993, 115,
3
+
+
23.8; LCMS: m/z: 198 (M+H) . HRMS calcd for C12H24NO (M+H) : 198.1857.
Found: 198.1855.
1
5
4
0183–10194; (e) Pearson, W. H.; Fang, W.-k.; Kampf, J. W. J. Org. Chem. 1994,
9, 2682–2684; (f) Pearson, W. H.; Fang, W.-k. J. Org. Chem. 1995, 60, 4960–
961; (g) Pearson, W. H. J. Heterocycl. Chem. 1996, 33, 1489–1496; (h) Pearson,
Compound 3f: 3,4-Dihydro-2-phenylbenzo[f][1,4]oxazepin-5(2H)-one (Table 1,
entry f): Light brown solid, mp = 126–127 °C. IR (KBr) max: 3405, 3035, 2924,
3
2853, 1743, 1608, 1484, 1230, 1113, 1032, 769, 696 cm ; H NMR (CDCl ,
m
À1
1
W. H.; Fang, W.-k. Isr. J. Chem. 1997, 37, 39–46.
300 MHz): d 8.60–8.57, (m, 1H), 7.53–7.42 (m, 6H), 7.29–7.23 (m, 2H), 7.17–
7.14 (m, 1H), 5.22 (dd, J = 1.5, 8.3 Hz, 1H), 5.11 (dd, J = 1.5, 13.2 Hz, 1H), 4.82
7
.
(a) Aubé, J.; Milligan, G. L. J. Am. Chem. Soc. 1991, 113, 8965–8966; (b) Aube, J.;
Milligan, G. L.; Mossman, C. J. J. Org. Chem. 1992, 57, 1635–1637; (c) Aube, J.;
Rafferty, P. S.; Milligan, G. L. Heterocycles 1993, 35, 1141–1147; (d) Milligan, G.
L.; Mossman, C. J.; Aubé, J. J. Am. Chem. Soc. 1995, 117, 10449–10459; (e)
Mossman, C. J.; Aube, J. Tetrahedron 1996, 52, 3403–3408; (f) Desai, P.;
Schildknegt, K.; Agrios, K. A.; Mossman, C.; Milligan, G. L.; Aubé, J. J. Am. Chem.
Soc. 2000, 122, 7226–7232; (g) Sahasrabudhe, K.; Gracias, V.; Furness, K.; Smith,
B. T.; Katz, C. E.; Reddy, D. S.; Aube, J. J. Am. Chem. Soc. 2003, 125, 7914–7922.
(a) Groutas, W. C.; Felker, D. Synthesis 1980, 861–868; (b) Colvin, E. W. Silicon
Reagents for Organic Synthesis, San Diego, 1983.
(dd, J = 9.8, 4.7 Hz, 1H); 13C NMR (CDCl
+ DMSO, 100 MHz): d 158.6, 151.8,
3
136.4, 132.1, 129.0, 128.0, 127.9, 125.1, 122.8, 120.5, 112.0, 77.7, 54.9; LCMS:
+
m/z: 239 (20, M) , 218 (30), 192 (100), 139 (50), 116 (75).
Compound 3g: 2,3,4,5-tetrahydro-1H-3-benzazepin-2-one (Table 1, entry g): pale
yellow solid, mp = 148–150 °C. IR (KBr)
m
max: 3420, 2924, 2855, 1732, 1523,
H NMR (CDCl , 300 MHz): d 7.40–7.28 (m, 4H),
5.62 (s, 2H), 4.62 (br s, 1H), 3.41–3.33 (m, 2H), 3.26–3.21 (m, 2H); C NMR
(CDCl , 75 MHz): d 172.6, 135.4, 131.2, 130.1, 128.8, 127.1, 124.6, 42.1, 40.0,
À1
1
1457, 1246, 1081, 754 cm
.
3
13
8
.
.
3
+
34.3; LCMS: m/z: 184 (100) (M+Na) .
9
(a) Bolm, C.; Legros, J.; Le Paih, J.; Zani, L. Chem. Rev. 2004, 104, 6217–6254; (b)
Ruping, M.; Nactshim, B. J.; Scheidt, T. Org. Lett. 2006, 8, 3717–3719; (c)
Komeyama, K.; Morimoto, T.; Takaki, K. Angew. Chem., Int. Ed. 2006, 45, 2938–
Compound 3h: Quinazoline-2,4-(1H,3H)-dione (Table 1, entry h): White solid,
mp = 295–298 °C. IR (KBr)
1485, 1355, 1263, 1126, 1009, 756, 649 cm
200 MHz): d 9.68 (br s, 1H), 9.25 (br s, 1H), 8.13 (d, J = 9.5 Hz, 1H), 7.43–7.29
(m, 3H); 13C NMR (CDCl
+ DMSO, 50 MHz): d 178.3, 154.8, 141.6, 133.3, 132.5,
mmax: 3392, 3310, 3106, 3031, 2952, 1695, 1601,
À1
1
;
3
H NMR (CDCl + DMSO,
2941; (d) Kischel, J.; Jovel, I.; Mertins, K.; Zapf, A.; Beller, M. Org. Lett. 2006, 8,
19–22; (e) Diaz, D. D.; Miranda, P. O.; Padron, J. I.; Martin, V. S. Curr. Org. Chem.
2006, 10, 457–476; (f) Iovel, I.; Mertins, K.; Kischel, J.; Zapf, A.; Beller, M. Angew.
3
+
124.8, 122.6, 121.4; LCMS: m/z: 162 (90, M) , 135 (30), 118 (35), 87 (100).
Compound 3i: 6-Methylquinazoline-2,4-(1H,3H)-dione (Table 1, entry i): Pale
Chem., Int. Ed. 2005, 44, 3913–3917.
1
1
0. Smith, P. A. S. In Molecular Rearrangements. Part I; de Mayo, P., Ed.; John Wiley &
Sons: New York, 1963; p 510.
1. Kate, P. T.; Mphalele, M. J.; Brown, M. E. J. Chem. Soc., Perkin Trans. 2 1995, 835–
yellow solid mp = 287–289 °C. IR (KBr)
1536, 1302, 1244, 1157, 971, 831, 737, 616 cm
200 MHz) d: 9.74 (br s, 1H), 7.61 (br s, 1H), 7.42–7.32 (m, 2H), 7.07 (d,
J = 8.0 Hz, 1H), 2.37 (s, 3H); 13C NMR (CDCl
+ DMSO, 50 MHz) d: 179.2, 154.5,
147.5, 136.4, 134.0, 132.5, 123.6, 116.0, 19.9; LCMS: m/z: 199 (70, M+Na) , 173
(100), 143 (35), 101 (45).
mmax: 3457, 3301, 2924, 1682, 1591,
À1
1
;
3
H NMR (CDCl + DMSO,
8
38.
3
+
1
1
1
2. Bunce, S. C.; Cloke, J. B. J. Am. Chem. Soc. 1953, 76, 2244–2248.
3. Misiti, D.; Rimatori, V. Tetrahedron Lett. 1970, 11, 947–950.
4. (a) Knunyants, L.; Fabrichnyi, B. P. Dok. Akad. Nauk. S.S.S.R. 1949, 68, 523–526;
Knunyants, L.; Fabrichnyi, B. P. Chem. Abstr. 1950, 1469; (b) Katoh, M.; Inoue,
H.; Honda, T. Heterocycles 2007, 72, 497–516.
Compound 3j: Isoquinoline-1,3,4-(2H)-trione (Table 1, entry j): Light brown
solid, mp = 227–229 °C. IR (KBr)
1379, 1304, 1137, 1051, 712, 647 cm ; 1 H NMR (CDCl + DMSO, 200 MHz) d:
3
10.98 (br s, 1H, NH), 7.78–8.00 (m, 4H); C NMR (CDCl + DMSO, 100 MHz) d:
mmax: 3448, 2921, 2851, 1750, 1637, 1463,
À1
1
3
3
1
1
5. ten Brink, G.-J.; Arends, I. W. C. E.; Sheldon, R. A. Chem. Rev. 2004, 104, 4105–
4
123.
169.8, 159.1, 149.6, 135.4, 134.9, 133.5, 132.6, 132.3, 122.7; EIMS: m/z: 174
+
6. (a) Eshghi, H.; Hassankhani, A. J. Korean Chem. Soc. 2007, 51, 361–364; (b)
Arisawa, M.; Yamaguchi, M. Org. Lett. 2001, 3, 311–312; (c) Luca, L. D.;
Giacomelli, G.; Porcheddu, A. J. Org. Chem. 2002, 67, 6272–6274; (d)
Ramalingan, C.; Park, Y. T. J. Org. Chem. 2007, 72, 4536–4538; (e) Eshghi, H.;
Gordi, Z. Synth. Commun. 2003, 33, 2971–2978; (f) Capuano, G.; Giammanco, L.
Gazz. Chim. Ital. 1956, 86, 119; (g) Ling, K. Q.; Ye, J. H.; Chen, X. Y.; Ma, D. J.; Xu,
J. H. Tetrahedron 1999, 55, 9185–9204.
(20, M À H) , 147 (MÀCO), 132 (20), 104 (100).
Compound 3n: N-(4-Iodophenyl)acetamide (Table 1, entry n): Brown solid,
mp = 142–144 °C. IR (KBr)
1387, 1310, 1250, 1001, 817,726 cm
9.62 (br s, 1H), 7.54–7.33 (m, 4H), 2.07 (s, 3H); C NMR (CDCl
100 MHz) d: 167.8, 137.9, 136.2, 120.5, 85.2, 23.3; LCMS: m/z: 283 (M+Na) ;
HRMS (ESI): calcd for C NONaI, 283.9548; found, 283.9540.
Compound 3q: N-(4-Methoxyphenyl)cyclopropanecarboxamide (Table 1, entry
q): White solid, mp = 125–127 °C. IR (KBr) max: 3302, 3007, 2922, 2852, 1648,
mmax: 3304, 3183, 2923, 2852, 1668, 1599, 1483,
À1
1
;
H NMR (CDCl
3
+ DMSO, 200 MHz) d:
+ DMSO,
13
3
+
8 8
H
1
7. General procedure: To
a
stirred solution of ketone (1.0 mmol) in 1,2-
(1.5 mmol) and FeCl (1.0 mmol).
dichloroethane (5 mL) were added TMSN
3
3
m
1
À1
The resulting mixture was stirred at room temperature for the appropriate
time (Table 1). After complete conversion as indicated by TLC, the solvent was
removed by evaporation and the residue was diluted with water and extracted
with ethyl acetate (2 Â 10 mL). The combined organic layers were dried over
1532, 1413, 1246, 1175, 1031, 827 cm
9.56 (br s, 1H), 7.46 (d, J = 8.8 Hz, 2H), 6.75 (d, J = 8.8 Hz, 2H), 3.76 (s, 3H), 1.75–
1.63 (m, 1H), 0.96–0.86 (m, 2H), 0.76–0.67 (m, 2H). 13C NMR (CDCl
, 100 MHz):
d 171.9, 156.3, 131.1, 121.4, 114.2, 55.5, 15.4, 7.8; LCMS: m/z: 192 (M+H) ;
HRMS (ESI): calcd for C11 14NO , 192.1024; found, 192.1014.
3
; H NMR (CDCl + DMSO, 200 MHz) d:
3
+
anhydrous Na
2
SO
4
and concentrated in vacuo. The resulting product was
H
2